関連する実験動画
Updated: Aug 31, 2025

11:53
Substrate Generation for Endonucleases of CRISPR/Cas Systems
Published on: September 8, 2012
27.5K
CraspaseはCRISPRRNA誘導によるRNA活性化プロテアゼである
Chunyi Hu1, Sam P B van Beljouw2,3, Ki Hyun Nam4
1Department of Molecular Biology and Genetics, Cornell University, Ithaca, NY 14853, USA.
まとめ
CRISPR誘導のカスパース (Craspase) は,標的RNA結合によって活性化され,Csx30に対するプロテアースの活性化を可能にします. この自己調節システムは,標的RNAの分裂後にプロテアゼ機能を停止します.
科学分野:
- 分子生物学
- 生物化学
- 構造生物学
背景:
- CRISPR-Cas型III-Eシステムは,エフェクタ複合体gRAMP/Cas7-11を使用しています.
- この複合体はTPR-CHAT/Csx29と結合し,Craspase酵素を形成する.
- CraspaseはCRISPR誘導のカスパースとして機能し,RNAターゲティングとプロテアースの活動がある.
研究 の 目的:
- Craspaseにおける標的RNAの分裂とプロテアゼの活性化のメカニズムを解明する.
- Craspaseの内生タンパク質基質を特定する
- Craspaseシステムの自己制御能力を理解するために
主な方法:
- Craspaseの構造のスナップショットをキャプチャするための冷凍電子顕微鏡 (cryo-EM).
- RNAの結合,分裂,およびプロテアゼの活性を研究する生化学的測定法.
- Craspaseのタンパク質基質の識別と特徴付け
主要な成果:
- 5'領域のターゲットガイドRNAのペアリングはゲーティングループを移動させ,構成変化を起こす.
- これらの変化は,プロテアスの触媒二酸化物をアロステリックに活性化し,基板結合ポケットを作成します.
- Csx30は内生基質として特定され,活性化Craspaseによってサイト特異的にタンパク質化されました.
- gRAMPによって標的RNAの分裂を阻害され,特定のRNA配列によって活性化されません.
結論:
- Craspaseは,固有の自己調節メカニズムを持つ新しいRNA活性化プロテアゼです.
- このシステムは,標的RNAの認識と分裂に関連した,プロテアゼの活性に対する正確な制御を示しています.
- この研究は,CRISPR-Casシステムの多様化に関する構造的およびメカニズム的な洞察を提供します.
関連する概念動画
CRISPR
52.7K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
52.7K
CRISPR and crRNAs
17.3K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
17.3K
CRISPR/Cas9 Genome Editing
178
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
178
The Antiviral System of Bacteria and Archaea: CRISPR
108
CRISPR stands for Clustered Regularly Interspaced Short Palindromic Repeats is a adaptive immune system found in bacteria and archaea that protects against viral infections. This system enables prokaryotic cells to identify, remember, and neutralize foreign genetic elements, primarily bacteriophages, by storing fragments of the invader’s DNA as a genetic memory.The CRISPR immune response begins during an initial infection. Cas (CRISPR-associated) proteins play a central role in this...
108
Caspases
12.7K
Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside...
12.7K
RNA Interference
26.4K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.4K

